国际肝病：在中国促红细胞生成素的应用如何？
Hepatology Digest: What about in China and the use of erythropoietin?
此外，在没有促红细胞生成素的血样中红细胞可以繁殖。
Moreover, erythroid colonies could be grown from blood samples without the need for exogenous erythropoietin.
目的探索兴奋剂促红细胞生成素(EPO)的检测方法。
Objective To find the detecting method of erythropoietin (EPO).
本文重点讨论了重组人促红细胞生成素的临床应用及其检测。
This paper mainly discussed the clinic applications of rHuEPO and its detecting techniques.
促红细胞生成素(EPO)是由肾脏分泌的内源性细胞因子。
Erythropoietin (EPO) is a kind of endogenesis cell factor which was excreted by the kidney.
促红细胞生成素是不容易被打破，因此它是初学者的最佳选择。
EPO is not easy to be broken, so it is the best choice for the beginners.
使用超纯透析液可改善血液透析患者炎症状态和促红细胞生成素抵抗。
Use of ultrapure dialysate should be beneficial to the inflammation status and ERI in long-term hemodialysis patients.
目的：观察肾组织移植对肾性贫血大鼠促红细胞生成素基因表达的影响。
OBJECTIVE: To investigate the effects of kidney tissue allograft transplantation on EPO gene expression in rats with renal anemia.
促红细胞生成素是一种天然的激素，可以促进含血红蛋白的红细胞的生成。
EPO is a natural hormone that stimulates production of the Hb-containing red blood cells.
促红细胞生成素与一氧化氮合酶抑制剂对肝硬化大鼠高动力循环状态的影响。
Effects of erythropoietin or nitric oxide synthesis inhibitor on hyperdynamic circulatory state in cirrhotic rats.
目的：探讨促红细胞生成素受体在慢性肾功能衰竭肾性贫血中的表达及意义。
Objective: to study the use of erythropoietin receptor in anemia of chronic renal failure.
促红细胞生成素是一种造血因子，临床中广泛应用于治疗各种原因造成的贫血。
Erythropoietin, the principal regulator of erythroids progenitor cells, is widely used to treat anemia caused by many diseases.
研究了用中国仓鼠卵巢细胞（CHO）生产促红细胞生成素（EPO）的配方。
The medium formulation have been studied to culture CHO cells producing erythropoietin(EPO).
目的研究癌性贫血患者血清促红细胞生成素水平及其与血红蛋白含量之间的关系。
Objective To study the relationship between levels of serum erythropoietin and haemoglobin in patients with anemia of cancer.
应用促红细胞生成素(EPO)是目前治疗癌症及放、化疗相关性贫血的主要方法。
Using epoetin (epo) has become the major treatment regimen for patients with cancer -, radiotherapy - and chemotherapy-related anemia.
因而重组促红细胞生成素对红细胞生成的刺激作用作为一种替代方法引起了人们的关注。
The stimulating effect of recombinant-erythropoietin (EPO-A) on erythropoiesis has raised interest in its administration as an alternative.
目的：了解促红细胞生成素治疗对于急性肾功能衰竭患者肾衰竭临床指标及预后的影响。
Objective: To evaluate the impact of erythropoietin on clinical parameters of patients with acute renal failure and the prognosis.
体外细胞培养及动物实验证明，促红细胞生成素对脑缺血损伤具有神经保护和治疗作用。
It has been proved that erythropoietin has neuroprotective effect and therapeutic action on cerebral ischemia in vivo and in vitro.
目的探讨促红细胞生成素和硫酸亚铁治疗用于小儿心脏手术的术前自体献血（AHT）。
Objective To explore erythropoietin(EPO) and ferrous sulfate therapy used to autohemotherapy(AHT) in the child cardiac operation.
目的探讨脑保护因子促红细胞生成素（EPO）与免疫炎性细胞因子在脑瘫发病中的作用。
Objective To investigate the effect of erythropoietin(EPO)as a brain-protective factor and inflammatory cytokines in the pathogenesis of cerebral palsy(CP).
背景资料：促红细胞生成素是一种天然存在的激素，对能对各种不同的细胞发挥多种作用。
Background: Erythropoietin is a naturally occurring hormone with multiple effects on a number of different cell types.
膳食摄入，促红细胞生成素使用，透析膜的选择，透析是否充分等均影响患者的营养情况。
The intake from diets, application of erythropoiesis stimulating factor, the selection of dialytic membrane and the adequate dialysis all rendered influence on their nutrition.
应用促红细胞生成素(EPO)是治疗非小细胞型肺癌在放、化疗相关性贫血的有效方法。
Using EPO to treat radiotherapy and chemotherapy relevant anemia in NSCLS is the effective method.
目的：探讨促红细胞生成素受体（EPOR）在慢性肾功能衰竭肾性贫血中的表达及意义。
Objective: To study the use of erythropoietin receptor (EPOR) in anemia of chronic renal failure.
血液透析病人血瘦素与BMI呈正相关，但重组人促红细胞生成素治疗可使两者相关性消失。
Leptin was positively correlated with BMI in HD patients, and EPO therapy can make the relationship disappear.
在这些患者的贫血用促红细胞生成素(EPO)治疗时，能观察到其心功能和症状明显改善。
When anemia in these patients is treated with erythropoietin (EPO), a significant improvement in cardiac function and symptoms was observed.
促红细胞生成素(EPO)是一种造血细胞生长因子，以往主要用于治疗多种原因所致的贫血。
Erythropoietin (EPO) is known as a classical hematopoietic growth factor of cells, which has been used to treat anemia caused by different reasons.
用促红细胞生成素治疗心力衰竭中的贫血，能够使心力衰竭患者的心功能和临床症状明显改善。
When anemia in these patients is treated with erythropoietin, a significant improvement in cardiac function and symptoms was observed.
用促红细胞生成素治疗心力衰竭中的贫血，能够使心力衰竭患者的心功能和临床症状明显改善。
When anemia in these patients is treated with erythropoietin, a significant improvement in cardiac function and symptoms was observed.
应用推荐